vRad names US Oncology exec CEO
by Brendon Nafziger, DOTmed News Associate Editor | May 01, 2012
George Morgan is vRad's new CEO.
Virtual Radiologic, the country's biggest teleradiology provider, named former US Oncology executive George Morgan its new CEO.
vRad said that starting Tuesday Morgan would step in for departing CEO and president Rob Kill.
Morgan spent the last seven years as chief operating officer with US Oncology, a network of more than 1,000 cancer doctors that was bought by McKesson in 2010. During his tenure, the company's revenues doubled, growing from $1.5 billion to $3 billion, vRad said.
Before joining US Oncology, Morgan led the ambulatory surgical division of the Hospital Corporation of America, vRad said.
vRad runs a network of more than 400 radiologists and also makes workflow and image sharing and storing software. Over the past few years, it has grown quickly, having bought rival teleradiology provider Nighthawk in late 2010.
vRad's outgoing CEO Kill was with the company for five years. His LinkedIn page lists his current position as a board member on an audit committee of Uroplasty Inc., a company that makes neuromodulation products to stop incontinence.
"George is a highly experienced and talented leader who will help vRad achieve its next stage of growth," Eran Broshy, chair of vRad's board of directors, and a senior advisor with the company's primary sponsor, Providence Equity Partners, said in a statement. "We also thank Rob Kill...for his leadership in successfully transitioning vRad from a niche teleradiology provider to the strong market leader it is today."
vRad said that starting Tuesday Morgan would step in for departing CEO and president Rob Kill.
Morgan spent the last seven years as chief operating officer with US Oncology, a network of more than 1,000 cancer doctors that was bought by McKesson in 2010. During his tenure, the company's revenues doubled, growing from $1.5 billion to $3 billion, vRad said.
Before joining US Oncology, Morgan led the ambulatory surgical division of the Hospital Corporation of America, vRad said.
vRad runs a network of more than 400 radiologists and also makes workflow and image sharing and storing software. Over the past few years, it has grown quickly, having bought rival teleradiology provider Nighthawk in late 2010.
vRad's outgoing CEO Kill was with the company for five years. His LinkedIn page lists his current position as a board member on an audit committee of Uroplasty Inc., a company that makes neuromodulation products to stop incontinence.
"George is a highly experienced and talented leader who will help vRad achieve its next stage of growth," Eran Broshy, chair of vRad's board of directors, and a senior advisor with the company's primary sponsor, Providence Equity Partners, said in a statement. "We also thank Rob Kill...for his leadership in successfully transitioning vRad from a niche teleradiology provider to the strong market leader it is today."
You Must Be Logged In To Post A CommentRegisterRegistration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now! |
|
